Considering Alternatives to Psychedelic Drug Prohibition
Kilmer, Beau, Priest, Michelle, Ramchand, Rajeev, C. Rogers, Rhianna, Senator, Ben, Palmer, Keytin
RAND Corporation eBooks January 1, 2024 DOI: 10.7249/rra2825-1 via OpenAlex
Summary
AI-generated from the abstractPsychedelic substances like psilocybin and LSD are being considered for treating mental health conditions, and more U.S. state and local governments are exploring policies that allow adults to use them for nonclinical reasons. This report provides new data and analysis to inform those policy discussions.
Study at a glance
| Characteristics | Report Peer reviewed |
|---|---|
| Keywords | Psychology |
| Citations | 4 |
| Key finding | New data and analysis are presented to inform policy discussions about allowing adult nonclinical use of psychedelic substances. |
Abstract
Psychedelic substances, such as psilocybin and LSD, have long been touted as holding promise for treating some mental health conditions. An increasing number of U.S. state and local governments are implementing or considering alternative policies to prohibiting some of these substances for nonclinical purposes (i.e., adults can use them for any reason). The authors of this report present new data and analysis to inform these discussions.